Delivery Order SPE2DB20D1109-SPE2DB23FN80M
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The $6,241.59 fixed-price contract has an ultimate completion date of August 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical commodities, including...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,185.24 fixed-price contract is for the delivery of 4565313658 units of the medication Isentress 400 mg Tablet 60s. The contract has an ultimate completion date of August 2, 2024. Amerisourcebergen is a for-profit organization that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,188.14 Firm Fixed Price delivery order is for the supply of ISENTRESS 400 mg tablets, a pharmaceutical product. The contract has a completion date of July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,982.36 Firm Fixed Price Delivery Order (SPE2DB20D1109|SPE2DB25FN04F) is for the delivery of 4566343247 - Isentress 400 mg Tablets. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,227.94 firm fixed-price delivery order is for the supply of Isentress 400 mg tablets. The award is not set aside and has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous contracts by defense and civilian agencies to provide a wide range of...
- This is a $3,133.98 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ISENTRESS 400 MG TABLET 60S, a pharmaceutical product, with a completion date of September 20, 2024. The contract is a firm fixed-price arrangement and has no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Isentress 400 MG Tablet 60s. The firm-fixed-price delivery order, valued at $1,185.24, has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The contract has a ceiling value of $10,631.13 and runs through January 17, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,288.10 firm fixed price delivery order is for the supply of Isentress 400 mg tablets, a specialty pharmaceutical product, to support military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) held by...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4564781478 ISENTRESS 400 MG TABLET 60S to the U.S. Department of Defense (DoD). The $1,412.21 firm fixed-price delivery order was awarded on June 3, 2024 and has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN80MDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Isentress 400 mg tablets. The $6,230.85 firm-fixed-price contract has an ultimate completion date of March 28, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract. Amerisourcebergen has a strong track record of federal contracting, with various awards from agencies like the Department of Justice Federal Bureau of Investigation, demonstrating its ability to deliver essential medical commodities to the government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 3/27/23 |